Search

Your search keyword '"Iking-Konert, Christof"' showing total 200 results

Search Constraints

Start Over You searched for: Author "Iking-Konert, Christof" Remove constraint Author: "Iking-Konert, Christof" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
200 results on '"Iking-Konert, Christof"'

Search Results

5. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

8. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination

9. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients

10. Aktualisierte Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit entzündlich-rheumatischen Erkrankungen im Rahmen der SARS-CoV‑2/COVID‑19-Pandemie einschließlich Empfehlungen zur COVID‑19-Impfung

13. The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis

14. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV-patients

16. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

18. Das Gemeinsame Vaskulitis-Register im deutschsprachigen Raum (GeVas) – eine Subgruppenanalyse der 131 RZA-Patienten

20. Serum Proteome Profiling Detects Myelodysplastic Syndromes and Identifies CXC Chemokine Ligands 4 and 7 as Markers for Advanced Disease

23. S2k‐Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 2: Therapie, Risikofaktoren und spezielle Fragestellungen

24. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics

25. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores

26. S2k‐Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 1: Klassifikation, Diagnostik, Prävention und Aktivitätsscores

27. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics

28. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scores

29. Statusbericht des GeVas Registers: Gemeinsames Vaskulitis Register im deutschsprachigen Raum zur prospektiven Auswertung des Langzeitverlaufs von Vaskulitis-Patienten

37. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial

42. Prävalenz, Gelenkbeschwerden und Assoziationen mit Haut- und Nagelbeteiligung bei Patienten mit Psoriasis-Arthritis - Ergebnisse der deutschen Querschnittsstudie an 1.827 Patienten

49. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2—methodology, key messages and justifying information.

Catalog

Books, media, physical & digital resources